Logo image
Rapid quantitative analysis of clarithromycin in rat plasma by UPLC-MS/MS after intravenous injection of the clarithromycin-loaded ultrafine PLGA nanoparticles
期刊文章   同儕審查

Rapid quantitative analysis of clarithromycin in rat plasma by UPLC-MS/MS after intravenous injection of the clarithromycin-loaded ultrafine PLGA nanoparticles

Yu-Jing Wang, Yi-Ting Wu, Jia-Yi Lin, Chih-Hung Chu, Hsin-Ying Huang, Yu-Chao Wang, Jen-Kun ChenChung-Shi Yang
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 卷.895-896, 頁碼.178-181
05/2012
PMID: 22483396

摘要

μ-SPE Clarithromycin Pharmacokinetics Rat plasma Ultrafine PLGA NP UPLC-MS/MS Analytical Chemistry Biochemistry Clinical Biochemistry Cell Biology
Nanoparticles were designed to encapsulate drugs to alter their pharmacological behaviors, therefore, it is very essential to monitor the pharmacokinetic profile of drug encapsulated in nanoparticles in order to clarify and predict their efficacy and side effects. In this paper, we reported a simple, rapid μ-elution 96-well solid phase extraction (μSPE) method combining with ultra high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) for determination of nanoformulated drug in rat plasma. This method presented satisfactory results in terms of sensitivity, precision, accuracy, and recovery, for the first time, of quantitatively analyzing clarithromycin (CLA) in rat plasma after intravenous administration CLA-loaded ultrafine PLGA nanoparticles for pharmacokinetic study. This method has been proved to be fast, reliable and reproducible to accurately analyze drug encapsulated in polymeric nanoparticles sample for a pharmacokinetic study. © 2012 Elsevier B.V.

相關連結

指標

1 檢視次數

詳細資料

Logo image